Armata Pharmaceuticals, Inc.
ARMP
$9.00
$0.182.04%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.69M | 14.76M | 4.33M | 11.69M | 9.29M |
| Total Receivables | 472.00K | 759.00K | 2.17M | 238.00K | 744.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.51M | 1.42M | 1.02M | 1.24M | 1.27M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 10.67M | 16.93M | 7.52M | 13.17M | 11.31M |
|
|
|||||
| Total Current Assets | 10.67M | 16.93M | 7.52M | 13.17M | 11.31M |
| Net Property, Plant & Equipment | 46.11M | 52.48M | 53.16M | 53.97M | 54.93M |
| Long-term Investments | 3.49M | 3.49M | 3.49M | 3.49M | 3.49M |
| Goodwill | 3.49M | 3.49M | 3.49M | 3.49M | 3.49M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 16.62M | 16.62M | 16.62M | 16.62M | 16.71M |
| Total Assets | 76.88M | 89.52M | 80.79M | 87.25M | 86.44M |
|
|
|||||
| Total Accounts Payable | 921.00K | 1.28M | 965.00K | 981.00K | 766.00K |
| Total Accrued Expenses | 2.98M | 2.56M | 2.16M | 1.98M | 3.57M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.56M | 135.61M | 116.82M | 107.24M | 43.39M |
| Total Finance Division Other Current Liabilities | 487.00K | 503.00K | 137.00K | 337.00K | 529.00K |
| Total Other Current Liabilities | 487.00K | 503.00K | 137.00K | 337.00K | 529.00K |
| Total Current Liabilities | 8.95M | 139.95M | 120.09M | 110.54M | 48.25M |
|
|
|||||
| Total Current Liabilities | 8.95M | 139.95M | 120.09M | 110.54M | 48.25M |
| Long-Term Debt | 256.92M | 15.24M | -- | -- | 55.44M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 26.53M | 26.84M | 27.13M | 27.42M | 27.69M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.08M | 3.08M | 3.08M | 3.08M | 3.08M |
| Total Liabilities | 295.48M | 185.10M | 150.29M | 141.03M | 134.46M |
|
|
|||||
| Common Stock & APIC | 282.94M | 281.65M | 281.06M | 280.48M | 279.72M |
| Retained Earnings | -501.53M | -377.24M | -350.56M | -334.27M | -327.74M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -218.60M | -95.59M | -69.50M | -53.78M | -48.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -218.60M | -95.59M | -69.50M | -53.78M | -48.02M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -218.60M | -95.59M | -69.50M | -53.78M | -48.02M |
|
|
|||||